巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Greenwich LifeSciences

    GLSI
    8.590
    0.600
    6.53%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Greenwich LifeSciences - 延遲價格・最後更新於 29/06 12:14
    最高位
    9.240
    最低位
    8.470
    開市價
    --
    前收市價
    9.190
    成交量(千)
    2.58
    成交額(百萬)
    0.21
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    111.67
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    48.960 - 6.824
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Greenwich LifeSciences
    證券代碼
    GLSI.US
    所屬板塊
    Biotechnology
    公司業務
    Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels.
    發行量
    13123377
    公司總部
    3992 Bluebonnet Drive, Building 14
    公司網址
    https://www.greenwichlifesciences.com
    公司電郵
    info@greenwichlifesciences.com
    公司電話
    +1 832 819-3232

    一天24次暫停交易 這支生物技術股飆升998%

    遲精蕊·
    一天24次暫停交易 這支生物技術股飆升998%

    關於

    Greenwich LifeSciences(GLSI.US)所屬的行業板塊為Biotechnology。
    Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels.
    詳細公司背景可參考: https://www.greenwichlifesciences.com